- Home
- ZBH
as of 12-29-2025 3:38pm EST
$90.73
$0.03
-0.03%
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
| Founded: | 1927 | Country: | United States |
| Employees: | N/A | City: | WARSAW |
| Market Cap: | 18.7B | IPO Year: | N/A |
| Target Price: | $107.00 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Hold | Number of Analysts: | 20 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.03 | EPS Growth: | -23.28 |
| 52 Week Low/High: | $85.33 - $114.44 | Next Earning Date: | 02-05-2026 |
| Revenue: | $8,010,900,000 | Revenue Growth: | 5.47% |
| Revenue Growth (this year): | 7.98% | Revenue Growth (next year): | 5.21% |
AI-Powered ZBH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 76.47%
76.47%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Zimmer Biomet Holdings Inc. News
ZBH Breaking Stock News: Dive into ZBH Ticker-Specific Updates for Smart Investing
Zacks
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
âž–
AI Sentiment
Neutral
5/10
Compare ZBH vs Leading Stocks
See how ZBH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ZBH Zimmer Biomet Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.